Form 4: Hologic Executive Sells Shares for Tax Obligations

Hologic's President of Breast & Skeletal, Mark W. Horvath, disposed of 113 common shares to cover tax obligations related to vested restricted stock units.

Summary

• Mark W. Horvath, President, Breast & Skeletal at Hologic Inc. (HOLX), reported a transaction involving the company's common stock.
• On February 10, 2026, 113 shares of common stock were disposed of at a price of $75.15 per share.
• This disposition was specifically for tax obligations incurred in connection with the settlement of restricted stock units (RSUs) for which service-based vesting requirements had been satisfied.
• Following this transaction, Mr. Horvath beneficially owns 23,026 shares of common stock, which includes 4,605 performance stock units/restricted stock units whose settlement has been deferred pursuant to the Issuer's Deferred Equity Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative transaction related to executive compensation, which typically has no material impact on the company's fundamental outlook or stock performance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholdings on restricted stock unit vesting, are common and generally not indicative of management's sentiment towards the company's future performance or a change in strategic direction.

Comparison to Industry Standards

• The practice of withholding shares to cover tax obligations upon the vesting of restricted stock units is a standard and widely accepted component of executive compensation plans across various industries, including healthcare technology. This transaction aligns with typical industry practices for managing equity awards.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine administrative transaction for tax purposes and does not reflect a change in the executive's investment thesis or company fundamentals.

Key Dates

Recommendation

This Form 4 details a routine disposition of shares by an executive to cover tax obligations upon the vesting of restricted stock units. Such transactions are administrative in nature and do not typically reflect a change in the executive's confidence in the company or its future prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Hologic, HOLX, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation